Jonathan Dalla-Riva (Former)
1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Genomic editing of metformin efficacy-associated genetic variants in SLC47A1 does not alter SLC47A1 expression
(
- Contribution to journal › Article
- 2019
-
Mark
The combined effects of FADS gene variation and dietary fats in obesity-related traits in a population from the far north of Sweden : the GLACIER Study
(
- Contribution to journal › Article
-
Mark
Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals
(
- Contribution to journal › Article
- 2015
-
Mark
ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP/PKA activation.
(
- Contribution to journal › Article
-
Mark
Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant.
(
- Contribution to journal › Article
- 2014
-
Mark
Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility.
(
- Contribution to journal › Article
-
Mark
Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice.
(
- Contribution to journal › Article
-
Mark
Superantigen activates the gp130 receptor on adipocytes resulting in altered adipocyte metabolism.
(
- Contribution to journal › Article
- 2013
-
Mark
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle.
(
- Contribution to journal › Article